EcoDrugPlus

Tubulin Beta 1 Class Vi

Ensembl ID : ENSOPRG00000002529
Gene Symbol: TUBB1
1 Cross references
186 Possible Orthologues:

Tubulin Beta 2a Class Iia

Ensembl ID : ENSOPRG00000000400
Gene Symbol: TUBB2A
1 Cross references
183 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSOPRG00000000403
Gene Symbol: TUBB2B
3 Cross references
181 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSOPRG00000017153
Gene Symbol: TUBB4A
3 Cross references
94 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSOPRG00000016816
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSOPRG00000014770
Gene Symbol: TUBB
1 Cross references
87 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSOPRG00000006441
Gene Symbol: TP53
1 Cross references
253 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSOPRG00000013584
Gene Symbol: TH
1 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSOPRG00000005899
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSOPRG00000016099
Gene Symbol: TIE1
1 Cross references
203 Possible Orthologues:

Utrophin

Ensembl ID : ENSOPRG00000009908
Gene Symbol: UTRN
1 Cross references
251 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSOPRG00000016146
Gene Symbol: VKORC1
1 Cross references
189 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).